NSC
33
6
NWSA
69
4
PRU
39
3
HPQ
55
3
KEY
24
2
DFS
64
4
GOOGL
62
6
DVA
62
5
MCO
67
3
DOW
47
4
NKE
36
2
M
40
3
AA
27
5
GRMN
53
3
PBI
30
-8
WMB
58
3
DOV
48
2
WHR
61
3
CMCSA
49
3
ADBE
50
3
NSC
33
6
NWSA
69
4
PRU
39
3
HPQ
55
3
KEY
24
2
DFS
64
4
GOOGL
62
6
DVA
62
5
MCO
67
3
DOW
47
4
NKE
36
2
M
40
3
AA
27
5
GRMN
53
3
PBI
30
-8
WMB
58
3
DOV
48
2
WHR
61
3
CMCSA
49
3
ADBE
50
3
Financhill
Back

PROCEPT BioRobotics 10K Form

Sell
5

PRCT
PROCEPT BioRobotics

Last Price:
$81.28
Seasonality Move:
4.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRCT News And Ratings

See the #1 stock for the next 7 days that we like better than PRCT

PRCT Financial Statistics

Sales & Book Value

Annual Sales: $136.2M
Cash Flow: $-19M
Price / Cash Flow: 0
Annual Sales: $4.63
Price / Book: 18.21

Profitability

EPS (TTM): -1.95000
Net Income (TTM): $-100.1M
Gross Margin: $71M
Return on Equity: -37.42%
Return on Assets: -25.56%

PROCEPT BioRobotics Earnings Forecast

Key PROCEPT BioRobotics Financial Ratios

  • The Gross Profit Margin over the past 5 years for PRCT is 52.17%.
  • The Selling, General & Administrative Expenses for PRCT have been equal to 96.76% of Gross Profit Margin.
  • The Research & Development expenses have been 35.57% of Revenue.
  • The Interest Expense is -3.77% of Operating Income.
  • The Net Earning history of PRCT is -77.76% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

PROCEPT BioRobotics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: PRCT
Website: procept-biorobotics.com

Debt

Debt-to-Equity Ratio: 0.21
Current Ratio: 6.02
Quick Ratio: 4.95

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRCT Technical Analysis vs Fundamental Analysis

Sell
5
PROCEPT BioRobotics (PRCT) is a Sell

Is PROCEPT BioRobotics a Buy or a Sell?